MELAS as an example of a mitochondrial disease

Journal of Applied Genetics

Volumn 42, Issue 3, 2001, Pages 351-358

  Piechota, Janusz ^a   Mroczek, Katarzyna ^a   Bartnik, Ewa ^a,b  

^a UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

MELAS; Mitichondrial diseases

Indexed keywords

EID: 0011818676     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BORNER G.V., ZEVIANI M., TIRANTI V., CARRARA F., HOFFMANN S., GERBITZ K.D., LOCHMULLER H., PONGRATZ D., KLOPSTOCK T., MELBERG A., HOLME E., PAABO S. (2000). Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum. Mol. Genet. 9: 467-475.
2. BRINI M., PINTON P., KING M.P., DAVIDSON M., SCHON E.A., RIZZUTO R. (1999). A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nat. Med. 5: 951-954.
3. Leu(UUR) mutation of mitochondrial DNA. Muscle Nerve 19: 187-190.
4. CHINNERY P.F., HOWELL N., ANDREWS R.M., TURNBULL D.M. (1999). Clinical mitochondrial genetics. J. Med. Genet. 36: 425-436.
5. CHINNERY P.F., HOWELL N., LIGHTOWLERS R.N., TURNBULL D.M. (1997). Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 120: 1713-721.
6. Leu(UUR) mutation causes amino-acylation deficiency and concomitant reduced association of mRNA with ribosomes. J. Biol. Chem. 275: 19198-19209.
7. DIMAURO S., BONILLA E., DE VIVO D.C. (1999). Does the patient have a mitochondrial encephalomyopathy? J. Child Neurol. 14 Suppl 1: S23-S35.
8. DUBEAU P., DE STEFANO N., ZIFKIN B.G., ARNOLD D.L., SHOUBRIDGE E.A. (2000). Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann. Neurol. 47: 179-185.
9. EMMERSON C.F., BROWN G.K., POULTON J. (2001). Synthesis of mitochondrial DNA in permeabilised human cultured cells. Nucleic Acids Res. 29: E1.
10. Leu(UUR) may cause an MERRF syndrome. Neurol. Neurosurg. Psychiatry 61: 47-51.
11. HESS J.F., PARISI M.A., BENNETT J.L., CLAYTON D.A. (1991). Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 351: 236-239.
12. JAMES A.M., SHEARD P.W., WEI Y.H., MURPHY M.P. (1999). Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations. Eur. J. Biochem. 259: 462-469.
13. JAMES A.M., WEI Y.H., PANG C.Y., MURPHY M.P. (1996). Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem. J. 318: 401-407.
14. KAUFMANN P., KOGA Y., SHANSKE S., HIRANO M., DIMAURO S., KING M.P., SCHON E.A. (1996). Mitochondrial DNA and RNA processing in MELAS. Ann. Neurol. 96: 172-180.
15. KAUKONEN J., JUSELIUS J.K., TIRANTI V., KYTTALA A., ZEVIANI M., COMI G.P., KERANEN S., PELTONEN L., SUOMALAINEN A. (2000). Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289: 782-785.
16. Leu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol. Cell Biol. 12: 480-490.
17. LEONARD J.V., SCHAPIRA A.H. (2000). Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355: 299-304.
18. LERTRIT P., NOER A.S., JEAN-FRANCOIS M.J., KAPSA R., DENNETT X., THYAGARAJAN D., LETHLEAN K., BYRNE E., MARZUKI S. (1992). A new disease-related mutation for mitochondrial encephalopathy lactic acidosis and strokelike episodes (MELAS) syndrome affects the ND4 subunit of the respiratory complex I. Am. J. Hum. Genet. 51: 457-468.
19. MANFREDI G., SCHON E.A., MORAES C.T., BONILLA E., BERRY G.T., SLADKY J.T., DIMAURO S. (1995). A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul. Disord. 5: 391-398.
20. Ser(UCN) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem. Biophys. Res. Commun. 214: 86-93.
21. PETRUZZEELLA V., MORAES C.T., SANO M.C., BONILLA E., DIMAURO S., SCHON E.A. (1994). Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum. Mol. Genet. 3: 449-454.
22. SCHON E.A. (2000). Mitochondrial genetics and disease. Trends Biochem. Sci. 25: 555-560.
23. Leu(UUR) mutation in MELAS: a model for pathogenesis. Biochim. Biophys. Acta 1101: 106-109.
24. SHANG J., CLAYTON D.A. (1994). Human mitochondrial transcription termination exhibits RNA polymerase independence and biased bipolarity in vitro. J. Biol. Chem. 269: 2911-2920.
25. VERMA A, MORAES C.T., SHEBERT R.T., BRADLEY W.G. (1996). A MERRF/PEO overlap syndrome associated with the mitochondrial DNA 3243 mutation. Neurology 46: 1334-1336.
26. Leu(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 275: 4251-4257.
27. (Lys) gene. Eur. J. Hum. Genet. 1: 80-87.